Salutem Insights Ltd.

What Salutem Insights Ltd. does

Salutem Insights Ltd. is an Irish health economics and market access consultancy founded in 2016 and headquartered in Ireland. The firm delivers professional services to enterprise pharmaceutical companies seeking to navigate the Irish reimbursement system, with a service portfolio spanning five core offerings: economic modelling and data analytics, education and field sales support, market access and price reimbursement strategy, HTA submission preparation (including submissions to the National Centre for Pharmacoeconomics), and HEOR and Real World Evidence generation. Its operational backbone is a six-person team of PhD- and MSc-credentialed specialists, several of whom previously held senior market access and patient access roles at major pharmaceutical manufacturers including GSK, Bayer, AbbVie, and ICON. The company is founder-led, with Managing Director Sandra Redmond directing client engagements alongside Head of Consulting Claire Barry and senior HTA and market access consultants.

The firm's underlying technology is principally human-expert health economics consulting supported by conventional quantitative analytics; there is no evidence of proprietary AI or platform products. Its go-to-market is sales-led and consultative, with senior leadership directly engaging enterprise pharma clients on project-based, quote-driven engagements. Marketing leverage comes through peer-reviewed publications, conference participation (ISPOR, PMI), LinkedIn presence, an email newsletter, and an active partnerships ecosystem including co-hosted events with IQVIA Ireland, Uniphar, and PMI, as well as research collaboration with AICRI and contributions to EU HTA webinars.

The business model is professional services revenue generated through project engagements; no public pricing is disclosed, and the firm has no external funding, parent company, or M&A history. Customer concentration is moderate by default given the narrow enterprise pharma segment and small team, though no client logos are publicly disclosed. Geographic focus is single-country (Ireland), with early signals of broader European reach via EU HTA collaboration.

Name

Salutem Insights Ltd.

Legal name

Salutem Insights Ltd.

Website

https://saluteminsights.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

1–10 employees

Short description

Salutem Insights Ltd. is an Ireland-based health economics and market access consultancy serving pharmaceutical companies with HTA submissions, economic modelling, HEOR, reimbursement strategy, and training services for the Irish market.

Ownership category

akta.pro rank

Headquarters

HQ city

Ireland

HQ country

Ireland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Health Economics Consulting Services: Professional consulting services for pharmaceutical companies including economic modelling, HTA submissions, market access strategy, and training. Revenue is generated through project-based consulting engagements with pharmaceutical clients seeking Irish market access expertise.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels5 records

Core offering

Salutem Insights Ltd. is an Irish health economics and market access consultancy that advises pharmaceutical companies on navigating the Irish reimbursement process. It delivers a portfolio of professional services covering economic modelling and data analytics, HTA submissions to the National Centre for Pharmacoeconomics (NCPE), market access, pricing, reimbursement and commercial strategy, HEOR and Real World Evidence generation, and education, training and field sales support.

Product overview

Salutem Insights is a health economics and market access consultancy offering a portfolio of professional services to pharmaceutical companies. The company's service offerings include: Economic Modelling and Data Analytics, Education Training and Field Sales Support, Market Access Price Reimbursement and Commercial Strategy, HTA Submission services, and HEOR and Real World Evidence capabilities. These services are designed to help pharmaceutical companies navigate the Irish reimbursement process and achieve market access for their products.

Differentiator

Problem solved

Functional benefit

Products and services

• Economic Modelling and Data Analytics

Quantifiable outcome

• Timelines to reimbursement: 357 days following Rapid Review and 914 days following HTA route
• +1 more outcomes

Named customers1 record

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Five partnerships are on record, tiered core and minor.

• IQVIAcoreStrategic or Co-development Partner · 8 October 2025Co-hosting a breakfast briefing on 'Real World Evidence in Market Access' with IQVIA Ireland, exploring RWE applications for obesity, orphan, and oncology medicines. Collaboration demonstrates strategic alignment in market access consulting.
• Accessus and Ecker + Ecker GmbHminorStrategic or Co-development Partner · 13 May 2025Supporting and contributing to the 2025 EU HTA Webinar Series hosted by Accessus and Ecker + Ecker GmbH, presenting the Irish perspective on EU HTA implementation.
• UnipharcoreStrategic or Co-development Partner · 13 June 2024Collaboration on Masterclass events including 'Exploring Pharma: From Drug Discovery to Dispensing' and joint webinar on market access challenges in Ireland. Uniphar provides venue support and cross-promotion.
• AICRI (All-Island Cancer Research Institute)coreStrategic or Co-development Partner · 24 April 2024Conducted research and produced the 'Landscape Review and Economic Potential of the Oncology and Allied Digital Health Sector on the Island of Ireland' report, funded under InterTradeIreland's Synergy programme. Collaboration with UCD and Queen's University Belfast.
• Pharmaceutical Managers Institute (PMI)coreGTM or Marketing Partner · 18 April 2024Ongoing collaboration for industry events including Masterclasses, Summits, and Stakeholder Briefings. Salutem Insights serves as sponsor and contributor to PMI events focused on market access and reimbursement.

Scale indicators2 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Mtech Access: UK-based market access consultancy providing HTA submissions, health economics, and payer engagement services to pharma. Closely comparable in service offering, customer base, and boutique consultancy model.
• PRMA Consulting: Global market access and HEOR consultancy specializing in HTA submissions, pricing, and reimbursement strategy for pharmaceutical clients. Directly comparable service portfolio to Salutem Insights, though operating at larger global scale.
• Valid Insight: Market access consultancy offering HTA submissions, value communications, and pricing/reimbursement strategy. Comparable boutique consultancy serving pharma clients across European markets.
• Ecker + Ecker GmbH: German HEOR and market access consultancy. Already a Salutem Insights collaboration partner on EU HTA webinar series, offering comparable HTA, pricing, and reimbursement services for pharma.
• Source Health Economics: Health economics and outcomes research consultancy providing HTA and market access support to pharmaceutical companies. Comparable in scale, service model, and specialization in HEOR.
• Cogentia Healthcare Consulting: European healthcare consultancy providing HTA, market access, and health economics services to pharmaceutical and medical device companies. Comparable in service portfolio and pharma focus.
• Market Access Solutions (MAS): Pharmaceutical market access consultancy providing HTA, pricing, reimbursement, and HEOR services. Comparable boutique model serving pharma clients across European and global markets.

Broad incumbents

• Health Economics and Outcomes Research (HEOR) at RTI Health Solutions: Health economics and outcomes research consultancy within RTI International, providing HTA submissions, economic modeling, and real-world evidence to pharmaceutical clients globally. Comparable service offerings at larger institutional scale.
• IQVIA: Global leader in clinical research, HEOR, and market access consulting. Directly comparable as it offers HTA submission, market access, and real-world evidence services to pharmaceutical clients, and is already a Salutem Insights co-hosting partner.
• ICON plc: Irish-headquartered global CRO with dedicated HTA, market access, and HEOR capabilities. Multiple Salutem team members previously worked at ICON, making it both a direct competitor and a talent pipeline source.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/salutem-insights-ltd

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Salutem Insights Ltd.